4/25
07:12 am
oncy
Oncolytics Biotech® Announces Upcoming Presentations at the American Society of Clinical Oncology Annual Meeting [Yahoo! Finance]
Medium
Report
Oncolytics Biotech® Announces Upcoming Presentations at the American Society of Clinical Oncology Annual Meeting [Yahoo! Finance]
4/25
07:00 am
oncy
Oncolytics Biotech® Announces Upcoming Presentations at the American Society of Clinical Oncology Annual Meeting
Medium
Report
Oncolytics Biotech® Announces Upcoming Presentations at the American Society of Clinical Oncology Annual Meeting
4/25
07:00 am
oncy
Oncolytics Biotech® Announces Upcoming Presentations at the American Society of Clinical Oncology Annual Meeting
Medium
Report
Oncolytics Biotech® Announces Upcoming Presentations at the American Society of Clinical Oncology Annual Meeting
4/11
09:15 am
oncy
Biotech Innovations Paving the Way in Breast Cancer Fight
Medium
Report
Biotech Innovations Paving the Way in Breast Cancer Fight
4/11
09:15 am
oncy
Biotech Innovations Paving the Way in Breast Cancer Fight
Medium
Report
Biotech Innovations Paving the Way in Breast Cancer Fight
4/11
07:06 am
oncy
Oncolytics Biotech® Advances Toward Registration-Enabling Trial for Pelareorep in Breast Cancer with Submission of Type C Meeting Request to FDA [Yahoo! Finance]
Low
Report
Oncolytics Biotech® Advances Toward Registration-Enabling Trial for Pelareorep in Breast Cancer with Submission of Type C Meeting Request to FDA [Yahoo! Finance]
4/11
07:00 am
oncy
Oncolytics Biotech® Advances Toward Registration-Enabling Trial for Pelareorep in Breast Cancer with Submission of Type C Meeting Request to FDA
Medium
Report
Oncolytics Biotech® Advances Toward Registration-Enabling Trial for Pelareorep in Breast Cancer with Submission of Type C Meeting Request to FDA
4/11
07:00 am
oncy
Oncolytics Biotech® Advances Toward Registration-Enabling Trial for Pelareorep in Breast Cancer with Submission of Type C Meeting Request to FDA
Medium
Report
Oncolytics Biotech® Advances Toward Registration-Enabling Trial for Pelareorep in Breast Cancer with Submission of Type C Meeting Request to FDA
4/4
02:40 pm
oncy
Oncolytics Biotech Inc. (NASDAQ: ONCY) is now covered by analysts at Raymond James. They set an "outperform" rating and a $3.00 price target on the stock.
Low
Report
Oncolytics Biotech Inc. (NASDAQ: ONCY) is now covered by analysts at Raymond James. They set an "outperform" rating and a $3.00 price target on the stock.
4/2
07:00 am
oncy
Oncolytics Biotech® to Participate in a Panel Presentation at Canaccord Genuity's Horizons in Oncology Virtual Conference
Medium
Report
Oncolytics Biotech® to Participate in a Panel Presentation at Canaccord Genuity's Horizons in Oncology Virtual Conference
3/14
08:45 am
oncy
Biotech's Role in Addressing the Pancreatic Cancer Emergency
Low
Report
Biotech's Role in Addressing the Pancreatic Cancer Emergency
3/14
08:45 am
oncy
Biotech's Role in Addressing the Pancreatic Cancer Emergency
Low
Report
Biotech's Role in Addressing the Pancreatic Cancer Emergency
3/10
08:52 am
oncy
Oncolytics Biotech Inc. (NASDAQ:ONCY) Q4 2023 Earnings Call Transcript [Yahoo! Finance]
Low
Report
Oncolytics Biotech Inc. (NASDAQ:ONCY) Q4 2023 Earnings Call Transcript [Yahoo! Finance]
3/7
04:09 pm
oncy
Oncolytics Biotech® Reports Fourth Quarter and Full Year 2023 Financial Results and Operational Highlights [Yahoo! Finance]
Low
Report
Oncolytics Biotech® Reports Fourth Quarter and Full Year 2023 Financial Results and Operational Highlights [Yahoo! Finance]
3/7
04:01 pm
oncy
Oncolytics Biotech® Reports Fourth Quarter and Full Year 2023 Financial Results and Operational Highlights
Low
Report
Oncolytics Biotech® Reports Fourth Quarter and Full Year 2023 Financial Results and Operational Highlights
3/6
08:11 am
oncy
Biotech/Oncology Stocks Targeting the Pancreatic Cancer Market - A Race Worth Winning [Yahoo! Finance]
Low
Report
Biotech/Oncology Stocks Targeting the Pancreatic Cancer Market - A Race Worth Winning [Yahoo! Finance]
3/5
08:41 am
oncy
Increasing Incidence of Pancreatic Cancer Leading to a $6.85 Billion Dollar Market Size for New Treatments [Financial Post (Toronto, Ontario, Canada)]
High
Report
Increasing Incidence of Pancreatic Cancer Leading to a $6.85 Billion Dollar Market Size for New Treatments [Financial Post (Toronto, Ontario, Canada)]
3/5
08:30 am
oncy
Increasing Incidence of Pancreatic Cancer Leading to a $6.85 Billion Dollar Market Size for New Treatments
Low
Report
Increasing Incidence of Pancreatic Cancer Leading to a $6.85 Billion Dollar Market Size for New Treatments
3/5
07:11 am
oncy
Oncolytics Biotech® Files Amendment to Initiate New Pancreatic Cancer GOBLET Cohort Supported by PanCAN [Yahoo! Finance]
High
Report
Oncolytics Biotech® Files Amendment to Initiate New Pancreatic Cancer GOBLET Cohort Supported by PanCAN [Yahoo! Finance]
3/5
07:00 am
oncy
Oncolytics Biotech® Files Amendment to Initiate New Pancreatic Cancer GOBLET Cohort Supported by PanCAN
Medium
Report
Oncolytics Biotech® Files Amendment to Initiate New Pancreatic Cancer GOBLET Cohort Supported by PanCAN
3/4
07:17 am
oncy
Oncolytics Biotech® to Host Conference Call to Discuss Fourth Quarter and Full Year Financial Results and Recent Operational Highlights [Yahoo! Finance]
High
Report
Oncolytics Biotech® to Host Conference Call to Discuss Fourth Quarter and Full Year Financial Results and Recent Operational Highlights [Yahoo! Finance]
3/4
07:00 am
oncy
Oncolytics Biotech® to Host Conference Call to Discuss Fourth Quarter and Full Year Financial Results and Recent Operational Highlights
High
Report
Oncolytics Biotech® to Host Conference Call to Discuss Fourth Quarter and Full Year Financial Results and Recent Operational Highlights
2/28
07:10 am
oncy
Oncolytics Biotech® Announces Presentation at the Cancer Advocacy Group of Louisiana's 3rd Annual NeauxCancer Conference [Yahoo! Finance]
Low
Report
Oncolytics Biotech® Announces Presentation at the Cancer Advocacy Group of Louisiana's 3rd Annual NeauxCancer Conference [Yahoo! Finance]
2/28
07:00 am
oncy
Oncolytics Biotech® Announces Presentation at the Cancer Advocacy Group of Louisiana's 3rd Annual NeauxCancer Conference
Low
Report
Oncolytics Biotech® Announces Presentation at the Cancer Advocacy Group of Louisiana's 3rd Annual NeauxCancer Conference
2/15
02:54 pm
oncy
Here's Why We're Watching Oncolytics Biotech's (TSE:ONC) Cash Burn Situation [Yahoo! Finance]
Low
Report
Here's Why We're Watching Oncolytics Biotech's (TSE:ONC) Cash Burn Situation [Yahoo! Finance]